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Ab s t r a c t
Increased ethylmalonic acid (EMA) in urine is a non-specific finding, and is observed in a number of inborn errors of
metabolism, as well as in individuals who carry one of two common polymorphisms identified in the SCAD coding
region. The authors present an 8-month-old girl with a suspicion of neuroinfection, although the clinical presenta-
tion led to diagnosis of ethylmalonic aciduria. From the neuropathological point of view the most remarkable changes
were observed in the brain cortex, which was diffusely damaged practically in all regions of the brain. Of note, the
most severe destruction was observed in the deepest regions of the sulci. The cortex of the affected regions showed
no normal stratification and its structure was almost totally replaced by a form of “granulation tissue” with a marked-
ly increased number of capillaries. To the authors’ knowledge this is the first clinical report of ethylmalonic aciduria
with brain autopsy findings.
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Case report
Introduction
Increased ethylmalonic acid in urine (EMA) is
a non-specific finding, and is observed in a number of
inborn errors of metabolism, as well as in individu -
als who carry one of two common polymorphisms
identified in the SCAD coding region [2,8]. Ethylma-
lo nic aciduria may be seen in short-chain acyl-co en -
zyme A dehydrogenase (SCAD) deficiency. It is also 
ob ser ved in patients with other disorders of mi to-
chondrial fatty acid oxidation, including the ethyl-
malonic encephalopathy syndrome, glutaric aci-
daemia type II (deficiency of electron transfer flavo-
protein and of electron transport flavoprotein –
ubiquinone oxidoreductase), and a large number of
still biochemically uncharacterized patients with per-
sistent elevated urinary EMA. 
Ethylmalonic encephalopathy (gene map locus:
19p13.32, mutations in the ETHE1 gene; MIM
#608451) coexists with MRI changes including
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increased signal on T2-weighted images in the puta-
men, caudate nuclei and periaqueductal region,
which correspond to symmetrical necrotic lesions
[1,5,12,20]. The patients occasionally have signal
abnormalities in subcortical white matter areas, and
brainstem, cerebral atrophy in frontal and temporal
regions, and cerebellar atrophy [9,12,14]. In some chil-
dren tethered cord, hygroma/haematoma and
a Chiari type I malformation may be found. Addition-
al biochemical abnormalities include elevated plasma
concentration of C4 and C5, acylcarnitine and some-
times elevated lactic acid with cytochrome oxidase
deficiency in muscle biopsy. The most frequent clini-
cal features observed in ethylmalonic encephalopathy
are petechiae, orthostatic acrocyanosis and chronic
diarrhoea [3,8]. Neurological assessment usually
shows developmental delay, microcephaly, cerebellar
ataxia, in the beginning hypotonia then pyramidal
and extrapyramidal dysfunction [6,16]. 
The literature data lead to the assumption that
ethylmalonic aciduria is a very rare disorder. However,
the actual incidence of the condition may be signifi-
cantly underestimated because the biochemical phe-
notype may be incorrectly attributed to other meta-
bolic disorders [15,18].
Patient presentation
An 8-month-old girl, the first daughter of young,
unrelated parents of Polish origin. The gestation pe -
riod was complicated by arterial hypertension in the
mother. The girl was born by vaginal, uneventful
delivery (birth weight of 3130 g, Apgar score of 10
points). In the family history febrile seizures were
observed. The psychomotor development was normal
since the 6th month of life. At the age of 6 months
a sudden episode of hypotonia and loss of reaction to
external stimuli in the course of viral infection was
noticed (contact with chickenpox in anamnesis).
A month later during bronchopneumonia and tem-
perature of 39°C status epilepticus was observed.
Due to cardio-respiratory insufficiency the girl was
admitted to the intensive care unit. Based on suspi-
cion of neuroinfection antibiotics and acyclovir were
introduced. In treatment mechanical ventilation, 
catecholamines, thiopental, phenytoin, phenobarbital
and valproic acid were used. CT of the head showed
mild cerebral atrophy in the frontal lobes. The cere-
brospinal fluid examination performed three times
was normal. PCR Herpes simplex was normal in 
plasma and cerebrospinal fluid. Adenovirus infection
was also excluded. 
Because of suspected neuroinfection after 
4 days the child was transferred to the Child Neuro -
logy Department. At admission the girl was sleepy,
without visual contact, and with weight deficiency
and hepatomegaly. Neurological examination
showed head circumference of 44 cm, frontal fon -
tanelle 4x4 cm, at the level of the cranial bone, spas-
tic tetraparesis, without clinical signs of increased
intracranial pressure. MRI showed contrast en -
hancement hyperintensity of the globus pallidus,
parietal and occipital lobes, less marked in the
frontal lobes and cerebellum [Figs. 1-8]. The changes
observed in MR imaging implied the suspicion of
neuroinfection (Herpes simplex?). The repeated MRI
(after 2 weeks of treatment) showed a small pro-
gression of changes especially conspicuous in the
temporal regions [Figs. 1-8]. Immunoglobulins were
added to the therapy regimen. In EEG generalized
paroxysmal changes were evident. Polymorphic
seizures (tonic seizures, partial secondary general-
ized seizures) were treated with phenytoin, clona -
zepam, and valproic acid. In laboratory examina -
tions increased transaminases (GPT 134 U/l, GOT
317 U/l), lactic acid (4.95 mmol/l), lactate dehydro-
genase (1824 U/l), and thrombocytosis (1223 K/uL)
were seen. Organic acid analysis in urine revealed
increased excretion of ethylmalonic acid and slight-
ly increased adipic acid. Increased plasma butyryl-
carnitine (C4) was proved by tandem mass spec-
trometry. On the 30th day of hospitalization the child
experienced high fever, recurrent vomiting, seizures,
oedema, and oliguria, followed by acute cardio-res-
piratory failure. After resuscitation the girl was
transferred to the ICU, where after several hours she
died. An autopsy was performed with special atten-
tion to the central nervous system. 
From the neuropathological point of view the
most remarkable changes were observed in the brain
cortex, which was diffusely damaged practically in all
regions of the brain. Of note, the most severe destruc-
tion was observed in the deepest regions of the sulci
[Fig. 9]. The cortex of the affected regions showed no
normal stratification and its structure was almost
totally replaced by a form of “granulation tissue” with
a markedly increased number of capillaries. Both in
the white matter and in the cortex marked astroglio-
sis was seen [Fig. 10]. Interestingly, in the most
severely affected regions, gliosis was almost absent
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(no GFAP-positive astrocytes), which strongly con-
trasted with remarkable gliosis in the vicinity of these
areas of total destruction of the cortex. In fully deve -
loped necrotic areas numerous macrophages were
observed in the cortex as well as in the white matter,
occasionally forming dense aggregations. In the
whole brain including the cerebellum there was
marked hypomyelination with gliosis, especially evi-
dent in GFAP immunohistochemistry.
The cerebellum was also evidently affected with
apparent hypoplasia (or atrophy) [Fig. 11]. Purkinje
cells were only sporadic and Bergman gliosis was 
conspicuous. The internal granular layer was pauci-
cellular. Focally remnants of fetal external granular
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Fig. 1. SE/T2 weighted MR images – lack of
myelination pattern in white matter of frontal
lobes, thin cerebral cortex.
Fig. 2. SE/T2 weighted MR images – myelination
pattern seen in internal capsules and partially in
corpus callosum. The remaining brain structures
do not show a proper myelination process.
Increased cerebral sulci with increased sub-
arachnoid spaces in frontal areas.
Fig. 3. SE/T1 MR weighted images – hyperin-
tense areas visible in frontal cortex indicative of
cortex passive hyperaemia.
Fig. 4. SE/T1 weighted MR images – high inten-
sity of signal areas seen in cerebral cortex of
right frontal and both occipital lobes indicative
of passive hyperaemia of the cortex.
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layer were observed. Some hypercellularity was noted
in the molecular layer of the cerebellar cortex, which
probably reflected a sort of retarded (or arrested)
migration from the external granular layer [Fig. 12].
Deep nuclei of the cerebellum and the brain stem
showed some neuron loss with concomitant gliosis.
In comparison to the brain cortex, basal ganglia were
relatively much less affected, with only a little
hypomyelination and loss of neurons.
In the general autopsy the liver was the most
affected organ, showing signs of extensive steatosis
of hepatocytes [Fig. 13] and scanty lymphocytic peri-
portal infiltrations (not shown).
Discussion
Ethylmalonic aciduria has been described in single
case reports. To the authors’ knowledge this is the
Fig. 5. FLAIR weighted MR images – white mat-
ter intensity of signal does not show pathologi-
cal changes, thin cerebral cortex in frontal areas.
Fig. 6. SE/T1 weighted MR images after enhance-
ment – in frontal cortex hyperintense signals
(more visible after contrast enhancement) sug-
gestive of passive hyperaemia of the cortex.
Fig. 7. SE/T1 weighted MR images after
enhancement – in the cortex of occipital lobes
more visible hyperintensity of signal suggestive
of cortex passive hyperaemia.
Fig. 8. SE/T1 weighted MR image after enhance-
ment – hyperintense linear areas in the cortex
of parietal and occipital lobes (right side) sug-
gestive of cortex passive hyperaemia.
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Fig. 9. Cerebral cortex most severely damaged in
the region of the bottom of the sulcus, with
somewhat partially preserved lateral parts of
sulcus. Haematoxylin-eosin.
Fig. 10. Massive astrogliosis in cerebral cortex.
GFAP immunohistochemistry.
Fig. 11. Cerebellum with features of conspicuous
hypoplasia. Haematoxylin-eosin.
Fig. 12. Cerebellar cortex. Remnants of external
granular layer, moderate hypercellularity in
molecular layer and marked loss of Purkinje
cells are noted. Haematoxylin-eosin.
Fig. 13. Microdroplet steatosis of hepatocytes.
Haematoxylin-eosin.
first clinical report with brain autopsy findings. 
Ethylmalonic aciduria is most often seen in SCAD
deficiency and ethylmalonic encephalopathy. Di Roc-
co et al. suggested that ethylmalonic aciduria is not
a constant biochemical marker of ethylmalonic
encepha lopathy and that its normal excretion outside
of metabolic decompensation episodes does not ex -
clude this metabolic disease [13,16]. Biochemically, all
patients have shown elevated excretion of ethylma -
lonic acid (EMA) in urine, supposedly from carboxyla-
tion of accumulated butyryl-CoA.
Over 20 confirmed cases of short-chain acyl-CoA
dehydrogenase (SCAD; McKusick 606885) deficiency
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(McKusick 201470) have been published, demonstrat-
ing an extraordinarily wide range of clinical symptoms
[16,20]. One group of patients showed mainly
episodes of acute, recurrent metabolic crises includ-
ing hypoglycaemia, metabolic acidosis, vomiting and
drowsiness [1,4,17,22]. A second group predominantly
demonstrated a neuromuscular picture with myopa-
thy and hypotonia, and seizures with or without men-
tal retardation [2,3,4,6,7]. In some cases a sort of tem-
porary swinging of symptoms typical for the first and
second group was observed [10,11]. A patient with
muscle weakness combined with ophthalmoplegia
and multicore myopathy has been described [19,20]. 
In our patient electron transfer flavoprotein and
electron transport flavoprotein dehydrogenase defi-
ciencies were excluded by absence of glutaric and iso-
valeric acids in the urine with isovaleryl and hexanoyl
glycines. Due to quick progression of symptoms the
presented patient was not subjected to either enzy-
matic or molecular study.
In neuropathological examination the cortical
changes cannot be regarded as specific. These
changes could be of ischaemic nature (the child was
reanimated twice) but the diffuse character and not
particularly specific topography of cortical damage as
well as its severity with enormous glial reaction sug-
gest that general metabolic derangements played an
important role in the brain pathology. 
The morphological picture should be differentiat-
ed from Alpers-Huttenlocher syndrome. However,
although no changes were found that could indicate
an inflammatory process (as in Alpers syndrome),
firstly, mild liver changes limited to fatty changes as
in our case occur in only a minority of cases of Alpers
syndrome (in those children the picture of nodular cir-
rhosis of the liver is typical), secondly, in Alpers syn-
drome loss of neurons, extensive vacuolation of the
cortex and astrocytosis are the dominant neuro -
pathological changes, and thirdly, as already men-
tioned, the severity and distribution of changes (with
relatively spared gyral crests) indicate the
ischaemic/metabolic nature of the pathology in the
reported case [10,20].
Increased concentration of ethylmalonate, along
with methylsuccinate, may be the only urinary orga -
nic abnormalities in patients with SCAD deficiency.
Ethylmalonic aciduria without methylsuccinate is also
found in oxidase cytochrome c deficiency. The combi-
nation of lactic acidosis, ethylmalonic and methylsuc-
cinic aciduria along with the excretion of butyryl-
glycine, isovalerylglycine and 2-methylbutyrylglycine
are characteristic for ethylmalonic aciduria. Despite
the suspicion of neuroinfection, the clinical presenta-
tion, laboratory tests and autopsy results most likely
point to the diagnosis of SCAD. 
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